{"screen_name":{"0":"NEJM","1":"NEJM","2":"NEJM","3":"NEJM","4":"NEJM","5":"NEJM","6":"NEJM","7":"NEJM"},"tweet_id":{"0":1319383028947283968,"1":1319367924008693760,"2":1319352826909331456,"3":1319350929834020866,"4":1319322626012098569,"5":1319307527738327042,"6":1319292433503416320,"7":1319277329806446592},"is_retweet":{"0":false,"1":false,"2":false,"3":true,"4":false,"5":false,"6":false,"7":false},"text":{"0":"A 52-year-old woman presented with painless, bilateral parotid swelling. Imaging showed dilatation of the parotid (Stensen\u2019s) ducts, and palpation resulted in profuse bilateral salivary discharge. A video shows saliva firing from the parotid ducts.","1":"The NEJM Race and Medicine topic page features a selection of NEJM articles on race and medicine with implications for improving patient care, professional training, research, and public health. All articles assembled on the page are freely available.","2":"Sensory ganglionopathy is characterized by sensory loss without weakness. A common pathophysiological mechanism is autoimmunity. This review focuses on acquired sensory ganglionopathies, most commonly seen in patients with an autoimmune disease or a paraneoplastic disorder.","3":"Even short, frequent exposures to people who have #COVID19 could lead to transmission, new CDC data suggest.","4":"Join clinical experts, thought leaders, and advocates for a collaborative discussion on the issues of health disparities, structural racism, and medicine as we examine specific dermatologic diseases. Register for 1 or all 4! @SkinofColor @VisualDx #skinofcolor #dermtwitter","5":"AK002, an anti\u2013Siglec-8 antibody, reduced eosinophils and symptoms of gastritis and duodenitis with frequencies of adverse events similar to placebo, although infusion-related reactions were more common with AK002.","6":"A chemo-free induction and consolidation first-line treatment of Ph-positive ALL with dasatinib and blinatumomab based on a targeted and immunotherapeutic strategy was associated with high incidences of molecular response and survival.","7":"Free Access: NEJM Covid-19 Articles and Resources. #COVID19 #SARSCoV2"},"user_verified":{"0":true,"1":true,"2":true,"3":true,"4":true,"5":true,"6":true,"7":true},"created_at":{"0":"2020-10-22 21:00:01","1":"2020-10-22 20:00:00","2":"2020-10-22 19:00:00","3":"2020-10-22 18:52:28","4":"2020-10-22 17:00:00","5":"2020-10-22 16:00:00","6":"2020-10-22 15:00:02","7":"2020-10-22 14:00:01"},"retweet_count":{"0":10,"1":24,"2":24,"3":16,"4":29,"5":3,"6":30,"7":34},"favorite_count":{"0":54,"1":60,"2":93,"3":0,"4":65,"5":13,"6":79,"7":61},"user_location":{"0":"Boston, MA","1":"Boston, MA","2":"Boston, MA","3":"Boston, MA","4":"Boston, MA","5":"Boston, MA","6":"Boston, MA","7":"Boston, MA"},"user_url":{"0":"http:\/\/t.co\/MskhpINH4c","1":"http:\/\/t.co\/MskhpINH4c","2":"http:\/\/t.co\/MskhpINH4c","3":"http:\/\/t.co\/MskhpINH4c","4":"http:\/\/t.co\/MskhpINH4c","5":"http:\/\/t.co\/MskhpINH4c","6":"http:\/\/t.co\/MskhpINH4c","7":"http:\/\/t.co\/MskhpINH4c"},"entities":{"0":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"1":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"2":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"3":{"hashtags":[{"text":"COVID19","indices":[70,78]}],"symbols":[],"user_mentions":[{"screen_name":"Physns1stWatch","name":"PhysiciansFirstWatch","id":130593087,"id_str":"130593087","indices":[3,18]}],"urls":[]},"4":{"hashtags":[{"text":"skinofcolor","indices":[248,260]},{"text":"dermtwitter","indices":[261,273]}],"symbols":[],"user_mentions":[{"screen_name":"SkinOfColor","name":"Skin of Color","id":3082314479,"id_str":"3082314479","indices":[225,237]},{"screen_name":"VisualDx","name":"VisualDx","id":30060614,"id_str":"30060614","indices":[238,247]}],"urls":[]},"5":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"6":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"7":{"hashtags":[{"text":"COVID19","indices":[51,59]},{"text":"SARSCoV2","indices":[60,69]}],"symbols":[],"user_mentions":[],"urls":[]}}}